The spontaneous development o chronic colonic inflammation in T cell receptor (TCR) mutant mice, in particular TCRalpha-mutant mice, provides an outstanding animal model of inflammatory bowel disease and a novel model to dissect mucosal immune regulatory mechanisms. The colonic disease in TCRalpha-mutant mice has many features of human ulcerative colitis. Colonies of mice mutant for TCRalpha, TCRbeta, TCRdelta and RAG-1 genes have been developed at the Massachusetts General Hospital. TCRalpha-mutant mice are being crossed with other mutant mice to develop TCRalpha-mutant mice deficient in B cells or a specific cytokine. The studies in these mice will involve characterization of the role of lymphocytes (T and B cell subsets, natural killer cells), antibodies and cytokines in the initiation and perpetuation of colonic inflammation. The studies include histological and immunohistological examination of tissues, flow cytometic and functional characterization of inflammatory cells in the colon, analysis of cytokines in the lymphoid tissues and the colon, detection of autoantibodies and antibacterial immune responses, and cell and serum transfer studies. The project will focus on the hypothesis that cytoline imbalance present at the mucosal site leads to unregulated immune responses to colonic luminal (bacterial) antigens resulting in chronic colonic inflammation. A major aim of the study will be to examine the role of the appendix and luminal bacteria in the development of inflammatory bowel disease. Experiments will also be designed to develop specific interventions in this model of inflammatory bowel disease, which will contribute to the development of new therapeutic modalities for human inflammatory bowel disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
2R01DK047677-04
Application #
2389432
Study Section
General Medicine A Subcommittee 2 (GMA)
Project Start
1994-09-15
Project End
2002-08-31
Budget Start
1997-09-01
Budget End
1998-08-31
Support Year
4
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Manocha, Monika; Rietdijk, Svend; Svend, Rietdijk et al. (2009) Blocking CD27-CD70 costimulatory pathway suppresses experimental colitis. J Immunol 183:270-6
Shimomura, Yasuyo; Mizoguchi, Emiko; Sugimoto, Ken et al. (2008) Regulatory role of B-1 B cells in chronic colitis. Int Immunol 20:729-37
Nanno, Masanobu; Kanari, Yasuyoshi; Naito, Tomoaki et al. (2008) Exacerbating role of gammadelta T cells in chronic colitis of T-cell receptor alpha mutant mice. Gastroenterology 134:481-90
Shimomura, Yasuyo; Ogawa, Atsuhiro; Kawada, Mayumi et al. (2008) A unique B2 B cell subset in the intestine. J Exp Med 205:1343-55
Sugimoto, Ken; Ogawa, Atsuhiro; Mizoguchi, Emiko et al. (2008) IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest 118:534-44
Nguyen, Deanna D; Maillard, Michel H; Cotta-de-Almeida, Vinicius et al. (2007) Lymphocyte-dependent and Th2 cytokine-associated colitis in mice deficient in Wiskott-Aldrich syndrome protein. Gastroenterology 133:1188-97
Yuan, Qian; Bromley, Shannon K; Means, Terry K et al. (2007) CCR4-dependent regulatory T cell function in inflammatory bowel disease. J Exp Med 204:1327-34
Mizoguchi, Atsushi; Ogawa, Atsushiro; Takedatsu, Hidetoshi et al. (2007) Dependence of intestinal granuloma formation on unique myeloid DC-like cells. J Clin Invest 117:605-15
Sugimoto, Ken; Ogawa, Atsuhiro; Shimomura, Yasuyo et al. (2007) Inducible IL-12-producing B cells regulate Th2-mediated intestinal inflammation. Gastroenterology 133:124-36
Maillard, Michel H; Cotta-de-Almeida, Vinicius; Takeshima, Fuminao et al. (2007) The Wiskott-Aldrich syndrome protein is required for the function of CD4(+)CD25(+)Foxp3(+) regulatory T cells. J Exp Med 204:381-91

Showing the most recent 10 out of 53 publications